Catalyst is a biopharmaceutical company focusing on protease therapeutics to address the disorders of coagulation systems.
Catalyst Biosciences is a drug discovery and development company. It is creating novel catalytic biopharmaceutical products based on engineered human proteases. It is developing proteases for the treatment of a broad range of diseases with a strong focus on hemostasis and inflammation. It is focused on protease therapeutics to address unmet medical needs in disorders of the coagulation systems.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 20, 2003 | Series Unknown | $60M | 2 | — | — | Detail |
Dec 5, 2002 | Series Unknown | $46M | 4 |
![]() |
— | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
![]() |
Yes | Series Unknown |
|
— | Series Unknown |
|
— | Series Unknown |
|
— | Series Unknown |
|
— | Series Unknown |
|
— | Series Unknown |